FDA Adds 6 More Meds to Pilot Program for Speedy Review of Drugs in the National Interest
Two obesity drugs are among the six new medications that could get faster FDA review under a new pilot program ...
Two obesity drugs are among the six new medications that could get faster FDA review under a new pilot program ...
In recent years, GLP-1 medications such as Ozempic, Wegovy and Zepbound have ballooned in popularity. While GLP-1s have, for years, ...
New research findings show a significant increase in the use of weight loss drugs among patients undergoing metabolic and bariatric ...
Pfizer’s internal obesity drug R&D stumbled, but the pharmaceutical giant is leaping ahead in this field through the multi-billion dollar ...
FDA leaders under President Donald Trump are moving to abandon a decades-old policy of asking outside experts to review drug ...
How can a biotech startup raise more than $1 billion over four plus years and say almost nothing publicly along ...
WASHINGTON — The Food and Drug Administration announced Friday that it has begun publishing reports of adverse events concerning drugs ...
Credit: Jack Botting, Yale University Non-antibiotic drugs can alter the microbiome and increase the risk of gut infections in surprising ...
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45.LONDON — ...
A major meta-analysis finds that patients who discontinue anti-obesity medications quickly regain weight, yet, crucially, they still retain some of ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.